Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ElixaMD vs No BS RX

By GLP-1 ScorecardUpdated

ElixaMD
Site position #269

Lower score

No BS RXFactor scores not reassessed.
Site position #23

Higher score

Score comparison

No BS RX has the higher recorded score — 82.8/100 to 63.7/100.

No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. No BS RX publishes separate prices for standard compounded, low-dose and brand-name programs.

Before you choose

Before comparing the headline prices, the ElixaMD review and the No BS RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, ElixaMD vs NuuVim and ElleS vs No BS RX compare each of them with another graded program, and the list of alternatives to ElixaMD ranks the programs closest to ElixaMD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNo BS RX +41
51
92
Dose & formulationNo BS RX +38
52
90
Clinical oversightElixaMD +20
92
72
Labs & monitoringNo BS RX +5
63
68
FulfillmentNo BS RX +18
76
94
Contract termsNo BS RX +29
45
74
ElixaMD · top barNo BS RX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricElixaMDNo BS RX
WeighScore63.7/10082.8/100
GradeCB−
Site position#269#23
Semaglutide$99/mo (first month; $199/mo refills, compounded)$149/mo advertised for standard compounded injection; low-dose priced separately
TirzepatideZepbound: $99 membership + medication (total not disclosed)$225/mo advertised for standard compounded injection; low-dose priced separately
CoverageCoverage not publishedConfirm program availability for your state
Brand-name accessYesYes
Oral / sublingualYesYes
ElixaMD

Site position #269 · C

Strengths

  • Compounded semaglutide offer states $99 for the first month and $199 for refills, including medication and shipping
  • Advertises a care portal, physician guidance and ongoing support
  • Names Triad Rx, RedRock Pharmacy and Beaker Pharmacy & Compounding
  • Advertises Wegovy pill, Wegovy injection and Zepbound options with a separate membership charge

What to consider

  • Branded medication costs are additional to the $99 membership; injection availability is qualified
  • Free dietitian visits depend on insurance and copay eligibility at the visit
  • Cancellation requires at least 72 hours before renewal; refund provisions have conditions
  • A complete public state-availability list was not established in this review
No BS RX

Site position #23 · B−

Factor scores not reassessed.

Strengths

  • Displays monthly and prepaid amounts by program
  • Advertises consultation, medication, shipping and messaging in the compounded plans
  • Lists branded Ozempic and Zepbound separately

What to consider

  • The $115 headline applies to low-dose programs
  • Plans renew automatically at the then-current rate
  • Cancellation generally stops future billing without refunding the current period

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard